Lung cancer accounts for a large percentage of cancer deaths worldwide. In the United States, an estimated 222,520 new diagnoses and 157,300 deaths associated with lung cancer were projected for 2010.1 Even with the best approaches available to us today, median 5-year survival rates range from 10% to 15% in advanced disease.2 The majority of our efforts have been aimed at prolonging survival, focusing on optimizing tumor-specific options. Unfortunately, we are prone to overlook symptoms that negatively impact quality of life. McCannon and Temel highlight approaches to managing the respiratory symptoms associated with advanced lung cancer, explaining the pathophysiology behind the common symptoms and critiquing the evidence behind these management approaches.
The authors emphasize the fact that multiple causes contribute to respiratory symptoms in patients with lung cancer. It is essential to perform a thorough history and clinical evaluation in order to elucidate the underlying insult(s) and not simply assume symptoms are due to progressive disease. The table gives an excellent framework to guide the approach to these patients. Reversible causes should always be sought and aggressively treated.
> more Quality-of-Life Issues articles
The Journal of Supportive Oncology
Focused on symptom and side-effect management, communication issues, and end-of-life care for patients with cancer.
For past issues, click here »
| Jun 1 - 5 Chicago, IL | American Society of Clinical Oncology (ASCO): Annual Meeting |
| Jun 14 - 17 Amsterdam, | European Hematology Association (EHA): Annual Congress |
| Jun 18 - 21 Lake Tahoe, NV | American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges |
| Jun 20 - 22 Milan, | European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference |
| Jun 25 - 26 London, | Teenage Cancer Trust (TCT): International Conference |
| Jun 27 - 30 Barcelona, | European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer |
| Jun 27 - 30 Boston, MA | American Association for Cancer Research (AACR): Chemical Systems Biology |
| Jun 28 - 30 New York, NY | Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium |
| Jun 28 - 29 Paris, | WIN 2012 Symposium |
| Jul 7 - 10 Barcelona, | 22nd Biennial Congress of the European Association for Cancer Research |